EAH Stock Overview
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide.
ECO Animal Health Group plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.99|
|52 Week High||UK£2.40|
|52 Week Low||UK£0.81|
|1 Month Change||-1.00%|
|3 Month Change||10.62%|
|1 Year Change||-37.14%|
|3 Year Change||-52.17%|
|5 Year Change||-83.29%|
|Change since IPO||197.00%|
Recent News & Updates
Calculating The Fair Value Of ECO Animal Health Group plc (LON:EAH)Mar 17
ECO Animal Health Group's (LON:EAH) Solid Earnings Have Been Accounted For ConservativelyDec 02
ECO Animal Health Group plc (LON:EAH) Shares Could Be 48% Below Their Intrinsic Value EstimateNov 16
Are Investors Undervaluing ECO Animal Health Group plc (LON:EAH) By 39%?Apr 30
Analysts Are Betting On ECO Animal Health Group plc (LON:EAH) With A Big Upgrade This WeekMar 09
Investors Who Bought ECO Animal Health Group (LON:EAH) Shares A Year Ago Are Now Up 58%Mar 06
Is ECO Animal Health Group (LON:EAH) Using Too Much Debt?Feb 08
An Intrinsic Calculation For ECO Animal Health Group plc (LON:EAH) Suggests It's 49% UndervaluedDec 18
|EAH||GB Pharmaceuticals||GB Market|
Return vs Industry: EAH underperformed the UK Pharmaceuticals industry which returned 6.2% over the past year.
Return vs Market: EAH underperformed the UK Market which returned -7% over the past year.
|EAH Average Weekly Movement||5.8%|
|Pharmaceuticals Industry Average Movement||5.5%|
|Market Average Movement||5.9%|
|10% most volatile stocks in GB Market||10.9%|
|10% least volatile stocks in GB Market||2.9%|
Stable Share Price: EAH is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: EAH's weekly volatility (6%) has been stable over the past year.
About the Company
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
ECO Animal Health Group plc Fundamentals Summary
|EAH fundamental statistics|
Is EAH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EAH income statement (TTM)|
|Cost of Revenue||UK£44.79m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.019|
|Net Profit Margin||1.60%|
How did EAH perform over the long term?See historical performance and comparison